Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Therapeutic delivery

• Publication date

  2013-09-11

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.4155/tde.13.75PMID 24024516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice.

  2020cited by this paper
• Nanotechnology platforms and physiological challenges for cancer therapeutics.

  2017cited by this paper
• Nanoparticles: Pushed off target with proteins.

  2013cited by this paper
• Liposomal drug delivery systems: from concept to clinical applications.

  2013cited by this paper
• Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

  2013cited by this paper
• Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.

  2013cited by this paper
• Development of Antibody-Based Therapeutics

  2012cited by this paper
• The Valley of Death in anticancer drug development: a reassessment.

  2012cited by this paper
• Pericyte-coverage of human tumor vasculature and nanoparticle permeability.

  2012cited by this paper
• Cancer stromal targeting (CAST) therapy.

  2012cited by this paper
• Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects.

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Potential of magnetic nanoparticles for targeted drug delivery.

  2012cited by this paper
• Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?

  2012cited by this paper
• Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".

  2012cited by this paper
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

  2012cited by this paper
• Preclinical models in radiation oncology

  2012cited by this paper
• Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles.

  2012cited by this paper
• Albumin-based nanoparticles as potential controlled release drug delivery systems.

  2012cited by this paper
• Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research

  2012cited by this paper
• A review on various targeted anticancer therapies

  2012cited by this paper
• Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.

  2012cited by this paper
• Enzyme-responsive nanoparticles for drug release and diagnostics.

  2012cited by this paper
• Clinical impact of serum proteins on drug delivery.

  2012cited by this paper
• Cancer nanomedicines targeting tumor extracellular pH.

  2012cited by this paper
• Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

  2012cited by this paper
• Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.

  2012cited by this paper
• The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Nanoparticle delivery for metastatic breast cancer.

  2012cited by this paper
• Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours

  2012cited by this paper
• Engineering nanomedicines using stimuli-responsive biomaterials.

  2012cited by this paper
• Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment.

  2012cited by this paper
• A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.

  2012cited by this paper
• "Targeting" nanoparticles: the constraints of physical laws and physical barriers.

  2012cited by this paper
• Peptide Targeted Lipid Nanoparticles for Anticancer Drug Delivery

  2012cited by this paper
• Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse

  2012cited by this paper
• Nanoparticle Based Drug Delivery System: Advantages and Applications

  2011cited by this paper
• Nanotechnology-mediated targeting of tumor angiogenesis

  2011cited by this paper
• Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.

  2011cited by this paper
• Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

  2011cited by this paper
• Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.

  2011cited by this paper
• Toxicology and clinical potential of nanoparticles

  2011cited by this paper
• In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.

  2011cited by this paper
• Targeted drug delivery to tumors: myths, reality and possibility.

  2011cited by this paper
• HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches.

  2010cited by this paper
• Nanomedicine.

  2010cited by this paper
• Hallmarks of cancer: interactions with the tumor stroma.

  2010cited by this paper
• Frontiers in cancer nanomedicine: directing mass transport through biological barriers.

  2010cited by this paper
• Nanotechnology in Head and Neck Cancer: The Race Is On

  2010cited by this paper
• Advances in the field of nanooncology

  2010cited by this paper
• Targeting of drugs and nanoparticles to tumors

  2010cited by this paper
• Drug delivery systems using polymer nanoassemblies for cancer treatment.

  2010cited by this paper
• Targeting nanoparticles to cancer.

  2010cited by this paper
• Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

  2010cited by this paper
• Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system.

  2010cited by this paper
• Current concepts: Nanomedicine

  2010cited by this paper
• Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery.

  2010cited by this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cited by this paper
• Human tumor xenografts and mouse models of human tumors: re-discovering the models

  2009cited by this paper
• Dendrimer-based nanoparticles for cancer therapy.

  2009cited by this paper
• Management of gestational diabetes mellitus

  2009cited by this paper
• Active targeting schemes for nanoparticle systems in cancer therapeutics.

  2008cited by this paper
• Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

  2008cited by this paper
• Gold nanoparticles in delivery applications.

  2008cited by this paper
• Conventional Chemotherapeutic Drug Nanoparticles for Cancer Treatment

  2007cited by this paper
• Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.

  2007cited by this paper
• Nanotechnology platforms and physiological challenges for cancer therapeutics

  2007cited by this paper
• Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

  2007cited by this paper
• Heterogeneous Breast Tumoroids: An In Vitro Assay for Investigating Cellular Heterogeneity and Drug Delivery

  2007cited by this paper
• Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize

  2007cited by this paper
• Barrier ' ' Microscopic Tumor Nodules : Consequences of a ' ' Binding Site An Analysis of Monoclonal Antibody Distribution in Updated

  2006cited by this paper
• Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology.

  2006cited by this paper
• Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

  2006cited by this paper
• Nanoparticles for cancer therapy and diagnosis

  2006cited by this paper
• Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system

  2005cited by this paper
• Nanostructure-mediated drug delivery.

  2005cited by this paper
• Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.

  2005cited by this paper
• Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer

  2004cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells

  2004cited by this paper
• Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

  2004cited by this paper
• Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

  2003cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.

  1994cited by this paper
• Drug targeting with nanoparticles

  1994cited by this paper
• Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.

  1992cited by this paper
• Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors.

  1989cited by this paper
• Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier.

  1988cited by this paper
• The Pharmacology of Monoclonal Antibodies a

  1987cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Copper Nanoclusters as Novel Podium for Cancer Detection, Imaging, and Therapy Applications.

  2024cites this paper
• Emerging Nanomaterials for Cancer Targeting and Drug Delivery

  2022cites this paper
• Application of nanoparticles in cancer therapy with an emphasis on cell cycle

  2021cites this paper
• Limitations of Current Cancer Theranostics

  2021cites this paper
• Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.

  2019cites this paper
• Facile sonochemistry-assisted assembly of the water-loving drug-loaded micro-organogel with thermo- and redox-sensitive behavior

  2019cites this paper
• Nanoparticles as new tools for inhibition of cancer angiogenesis

  2018cites this paper
• Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs.

  2017cites this paper
• Folate-functionalized assembly of low density lipoprotein/sodium carboxymethyl cellulose nanoparticles for targeted delivery.

  2017cites this paper
• Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer.

  2016cites this paper
• Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes.

  2015cites this paper
• Lokalisation und Quantifizierung der Aufnahme von Nanokristallen in der Leber

  2014cites this paper